Egle Ramelyte

19PUBLICATIONS

54CO-AUTHORS

Tumour immunologyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (19)

Sort by Publication Date:

|Jun 09, 2026

Depicting the Immunological Landscape of Basal Cell Carcinoma Subtypes.

|Apr 27, 2026

Re-Exposure of a PD-1 Inhibitor After Previous Immune-Related Adverse Events.

|Mar 28, 2026

Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in Melanoma.

Andrew E Quacoe, Sandra N Freiberger, Mitchell P Levesque

|Feb 25, 2026

Safety of Multi-Omics-Guided Therapy in Advanced Melanoma: A Matched Comparative Cohort Analysis.

Benedict Gosztonyi, Tarun Mehra, Gabriele Gut

|Jan 10, 2026

Neoadjuvant Therapy in Resectable Advanced Melanoma: Swiss Real-World Data.

Ann-Kathrin Blumenröther, Yongxing Fang, Tamara El Saadany

|Dec 12, 2025

Circulating Tumor DNA Is Prognostic of Patient Outcome and Enables Therapy Monitoring in Metastatic Uveal Melanoma.

Egle Ramelyte, Julian Kött, Aleigha R Lawless

Pageof 4

Frequent Collaborators

15 joint publications

Reinhard Dummer

Mitchell P Levesque

Patrick Turko

Sandra N Freiberger

M C Nägeli

Amélie Ciernik

Julia M Martínez-Gómez

2 joint publications

Johanna Mangana

2 joint publications

Ramon Staeger

1 joint publications

Laurence Imhof

Frequent Collaborators

15 joint publications

Reinhard Dummer

8 joint publications

Mitchell P Levesque

3 joint publications

Patrick Turko

3 joint publications

Sandra N Freiberger